Bovotica – Andrew Leech

The elevator pitch

The synbiotic technology reduces methane emissions in cattle by up to 80% while simultaneously delivering a 10% production efficiency.

About Andrew Leech

Dr Leech has over twenty years’ experience developing technology in the biotech industry, commercialising animal health, aquaculture, agriculture, and human therapeutic products. As Chief Executive Office of Bovotica Dr Leech’s role is to coordinate the efforts of a worldclass research and development team to develop precision microbiome modulators to reduce enteric methane while simultaneously delivering a production efficiency.

Dr Leech completed his postdoctoral studies at Virginia Commonwealth University, and he has a PhD in Biochemistry from the University of Queensland. He completed his legal studies through the University of Technology Sydney, and he is registered as a patent and trademark attorney. Dr Leech currently sits on the Board of several biotechnology companies.

As a keen American barbecuer and cheesemaker, safeguarding the beef and dairy industries in the face of climate change is not just his job, it’s his passion.

Principal Partners

Skip to content